The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs.

MLA

Zhang, Yuan, et al. “The Peripheral Blood Neutrophil-to-Lymphocyte Ratio Is a Prognostic Predictor for Survival of EGFR-Mutant Nonsmall Cell Lung Cancer Patients Treated with EGFR-TKIs.” Medicine, vol. 97, no. 30, July 2018, p. e11648. EBSCOhost, https://doi.org/10.1097/MD.0000000000011648.

APA

Zhang, Y., Feng, Y.-C., Zhu, H.-G., Xiong, T.-C., Hou, Y.-S., Song, J., Jiang, W., & Zhu, C.-J. (2018). The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs. Medicine, 97(30), e11648. https://doi.org/10.1097/MD.0000000000011648

Chicago

Zhang, Yuan, Yang-Chun Feng, Hong-Ge Zhu, Ting-Chuan Xiong, Yan-Shen Hou, Jia Song, Wei Jiang, and Chang-Jun Zhu. 2018. “The Peripheral Blood Neutrophil-to-Lymphocyte Ratio Is a Prognostic Predictor for Survival of EGFR-Mutant Nonsmall Cell Lung Cancer Patients Treated with EGFR-TKIs.” Medicine 97 (30): e11648. doi:10.1097/MD.0000000000011648.